Home / ARA 290*10vials

ARA 290*10vials

Research-grade ARA-290 (Cibinetide) is an 11-amino-acid linear peptide derived from the helix-B surface of erythropoietin (EPO).
Quantity
ADD TO CART
BUY IT NOW
  • Detail

    ARA-290 (Cibinetide) (PyroGlu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser) is a non-erythropoietic EPO derivative developed by Araim Pharmaceuticals. It selectively binds the innate repair receptor (IRR = EPOR-β common receptor complex) without increasing hemoglobin or red blood cell count. 

    Key Scientific Features

    • High-purity ARA-290 (≥ 99% by HPLC/MS, acetate salt form)
    • Verified 11-amino-acid sequence: pyroGlu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
    • Lyophilized formulation for long-term stability
    • Full Certificate of Analysis (COA) with HPLC, MS, amino acid analysis, and IRR binding assay
    • Manufactured in GMP-aligned, ISO-compliant facilities
    • Suitable for IRR activation and tissue-protection research models

    Research Applications

    • In vitro and preclinical IRR binding and selectivity studies
    • Non-erythropoietic EPO derivative research
    • Inflammatory pathway and cytokine research models (TNF-α, IL-6)
    • Cell-based apoptosis and tissue-repair mechanism studies
  • Customer Reviews
    No comments